Breast Surgery in Metastatic Breast Cancer: Local Control Without Survival Benefit
Randomised trials show breast surgery improves local disease control but not overall survival in de novo metastatic breast cancer.
Posted innews OB/GYN & Women's Health Oncology
Trastuzumab Deruxtecan Plus Pertuzumab: A Promising First-Line Therapy for HER2-Positive Metastatic Breast Cancer
Trastuzumab deruxtecan combined with pertuzumab significantly improves progression-free survival over standard therapy in first-line HER2-positive metastatic breast cancer, offering enhanced response duration with manageable safety.